The results demonstrated meaningful reductions in the severity of involuntary movements and notable improvements in patient-reported quality of life
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
If approved, tavapadon will enhance AbbVie's leadership in Parkinson's disease by providing patients with a once daily oral treatment option
Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus
Prucalopride is prescribed for chronic idiopathic constipation
Athena is also exploring the use of this technology for expanded carrier screening
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Subscribe To Our Newsletter & Stay Updated
